Logo of BIofidus AG
3d render of AAVs, nanobodies and blue igG antibodies binding receptors on a white t-cell in a red blood vessel scene generated by Biofidus AG


Characterization of biologics

Biologics and their biosimilars comprise the cutting-edge of biopharmaceutical products such as antibodies, enzymes, AAVs, vaccines or hormones used to treat many complex conditions, including cancer, neurologic and autoimmune disorders, and diabetes. Biologics are far from easy to characterize as they are highly complex mixtures of biological compounds produced by natural sources like cell cultures or microorganisms.​

We at Biofidus are well experienced with a wide variety of biologics. Through hundreds of projects with small and big pharma clients we were able to build up broad knowledge in characterizing different classes of biologics including IgGs, bispecific antibodies, nanobodies, antibody-drug conjugates (ADCs), fusion proteins and vector-based therapeutics. From structural and functional characterization, from the identification of impurities to complex comparability or forced degradation studies.

Get in contact with us to find the optimal strategy for your project and to speak directly from expert to expert.​

Tell us about your project

We‘ll advice you to define your assay needs

By sending the contact form you agree to our privacy policy.
*By submitting this form, you are consenting to receive emails from: Biofidus AG. You can revoke your consent at any time by using the unsubscribe link, found at the bottom of every email. Please see our privacy policy.

Technologies used

Our CEO Dr. Benjamin Müller is your contact person for all requests concerning the general topic of Biologics.

Phone: +49(0)521 89 739 060
Mail: Benjamin.Mueller@Biofidus.com

WordPress Cookie Hinweis von Real Cookie Banner